Table 6.
The effect of covariates on the percentage of egg reduction rates greater than 90 % among children infected with schistosomes following treatment with praziquantel
| Covariates | Levels | Percentage ERR > 90 % (95 % BCI) |
|---|---|---|
| Schistosoma haematobium dataset | ||
| (Baseline) | Côte d’Ivoire; male; younger SAC; 40 mg/kg; 21 days follow-up | 95.9 % (89.3 %, 99.1 %) |
| Country | Kenyaa | 98.3 % (94.3 %, 99.7 %) |
| Sex | Female | 97.3 % (92.2 %, 99.4 %) |
| Age group | Older SAC | 92.3 % (82.6 %, 97.6 %) |
| Schistosoma mansoni dataset | ||
| (Baseline) | Côte d’Ivoire; male; younger SAC; 40 mg/kg; 21 days follow-up | 94.4 % (85.3 %, 98.3 %) |
| Country | Uganda | 75.9 % (59.7 %, 86.4 %) |
| Dose | 60 mg/kg | 92.3 % (77.8 %, 98.1 %) |
| Sex | Female | 92.6 % (81.8 %, 97.6 %) |
| Age group | Pre-SAC | 90.9 % (78.1 %, 97.2 %) |
| Older SAC | 95.5 % (85.8 %, 99.0 %) | |
| Follow-up time | 28 days | 89.5 % (80.4 %, 95.0 %) |
| 42 days | 59.1 % (39.7 %, 76.4 %) | |
aChildren in Kenya were followed up for 42 days
Abbreviations: BCI Bayesian credible interval, SAC school-age children